A way to revive failed livers through stem cells could be available within the next few years as clinical tests of a new treatment regimen are underway. Pharmicell, a Korean pharmaceutical company developing stem cell therapeutics, said Monday that it has submitted a plan for the commercialization of “Livercellgram,” a stem cell therapy for liver failure, to the Korea Food and Drug Administration (KFDA).
View the original article here: Stem cells may cure liver failure – Korea Times